1. Taiwan Stocks

  2. •

    Distribution services

  3. •

    Medical distributors
Excelsior Medical Co., Ltd.

Excelsior Medical Co., Ltd.

TTWSE:4104
73.20
TWD
-0.30
(-0.41%)
5.75EPS
13.78P/E
12.94BMarket Cap
Nov 06Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
40.53
41.1
42.79
39.35
38.16
40.09
40.77
38.4
39.56
41.2
47.2
48.95
50.38
51.28
Basic EPS, GAAP
2.12
2.02
2.61
2.47
2.5
2.85
3.25
3.29
3.65
3.83
4.28
4.42
4.62
4.98
Free Cash Flow per Basic Share
1.89
5
4.91
2.65
-3.28
0.99
7.21
4.8
4.67
2.66
-0.2
13.48
-8.29
2.4
Dividend per Share
1.6
1.6
1.95
1.93
2
2.26
2.43
2.68
2.97
2.83
3.1
3.39
3.56
- -
Book Value per Share
43.12
43.62
42.57
40.81
40.15
42.47
43.86
43.51
44.36
47.01
49.37
51.42
52.69
52.1
Tangible Book Value per Share
42.62
43.08
42.13
40.54
39.9
42.22
43.66
43.33
44.17
46.83
49.11
51.15
52.43
50.94
Basic Weighted Avg Shares
142
141
145
158
160
158
158
174
166
174
174
174
174
179
Sales/Revenue/Turnover
5,741
5,807
6,203
6,206
6,095
6,345
6,457
6,675
6,573
7,187
8,233
8,539
8,789
9,201
Operating Margin (%)
5.38
5.92
5.61
6.12
7.42
7.1
7.25
7.97
9.18
8.64
8.45
8.78
8.25
7.97
Depreciation Expense
123
123
125
97
85
80
160
167
203
222
266
301
314
324
Net Income, GAAP
300
286
379
390
399
452
515
572
607
667
747
771
806
894
Effective Tax Rate (%)
21.29
21.76
14.49
17.51
15.02
15.43
16.68
19.33
17.33
18.51
19.34
17.31
18.3
18.2
Profit Margin (%)
5.22
4.92
6.11
6.28
6.55
7.12
7.97
8.56
9.24
9.29
9.07
9.03
9.17
9.72
Working Capital
2,665
3,289
4,516
4,757
4,125
4,833
3,786
4,482
4,353
3,776
4,013
3,932
4,174
5,682
LT Debt
16
18
537
320
- -
- -
164
225
210
182
237
378
670
1,527
Total Equity
7,482
7,854
8,178
8,309
8,025
8,342
8,632
9,580
9,746
10,297
10,913
11,357
11,725
13,204
Return on Invested Capital (%)
2.78
2.87
3.09
3.25
4.02
3.89
3.93
5.03
5.66
5.43
5.39
5.5
4.97
4.7
Return on Capital (%)
3.52
2.45
3.34
3.49
3.72
3.94
4.37
4.74
4.8
5.16
4.98
4.72
5.06
5.58
Return on Common Equity (%)
5.09
4.65
6.02
6.03
6.17
6.83
7.49
7.86
7.92
8.38
8.88
8.77
8.87
9.78

Capital Structure

TWD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
1,490
526
887
LT Borrowings
350
350
350
LT Finance Leases
320
330
1,177
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
174
188
188
Market Capitalization
14,000
14,504
12,941

Working Capital

TWD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
10,366
10,813
11,672
Cash, Cash Equivalents & STI
3,534
3,816
4,528
Accounts Receivable, Net
1,770
1,893
2,050
Inventories
1,392
1,409
1,429
Total Current Liabilities
6,192
6,343
5,990
Payables & Accruals
- -
- -
- -
ST Debt
1,490
526
887
Deferred Revenue
- -
- -
- -

Growth Rates

TWD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
3.73%
4.13%
3.23%
Free Cash Flow
-682.32%
-1,406.29%
-161.54%
Net Income, GAAP
7.92%
7.16%
4.49%
Sales/Revenue/Turnover
3.65%
5.8%
2.94%
Total Cash Common Dividend
- -
- -
5%

Quarterly Revenue

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
2,042
2,160
2,059
2,278
8,539
2025
2,149
2,168
2,192
2,281
8,789
2026
2,343
2,386
- -
- -
- -

Quarterly Earnings Per Share

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1.06
1.26
0.99
1.1
4.42
2025
1.18
1.41
1.07
1.11
4.62
2026
1.12
1.66
- -
- -
- -

Quarterly Dividends Per Share

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
3.39
2025
- -
- -
- -
- -
3.56
2026
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Ming Cheng Chang
Full Time Employees
774
Sector
Distribution services
Industry
Medical distributors
Address
No. 880, Zhongzheng Road Taipei TPE Taiwan 235
IPO Date
Jun 8, 2001
Website
excelsiormedical.com.tw
Similar Companies
DataMeds AI, Inc. (NASDAQ:MEDS)
Selcuk Ecza Deposu Ticaret ve Sanayi A.S. (BIST:SELEC)
McKesson Corporation (NYSE:MCK)
Ibnsina Pharma (EGX:ISPH)
Cardinal Health, Inc. (NYSE:CAH)
Entero Healthcare Solutions Limited (NSE:ENTERO)
Business
Excelsior Medical Co., Ltd. is a Taiwan-based company primarily engaged in the manufacture and sale of medical devices and healthcare products. Its core product portfolio includes diagnostic instruments; disposable medical consumables such as syringes, needles, and catheters; protective medical equipment; and surgical instruments. The company provides comprehensive healthcare solutions to hospitals, clinics, and healthcare professionals across Taiwan and international markets. Founded in 1985 and headquartered in Taichung, Taiwan, Excelsior Medical serves diverse segments within the medical device industry, focusing on quality and innovation in patient care products. In the past two years, Excelsior Medical has strategically expanded its product line to include advanced diagnostic tools and launched new disposable medical devices designed for improved safety and efficiency. The company has established recent partnerships with regional healthcare providers to strengthen distribution channels and enhance market presence. It has also invested in upgrading its manufacturing technologies to support higher production standards and meet increasing demand domestically and abroad. These operational changes reflect Excelsior Medical's commitment to innovation and market expansion in the medical technology sector. The company operates mainly in Taiwan but extends its sales and marketing efforts to key Asian markets and select global regions through subsidiaries and partner networks. Excelsior Medical's business segments include medical device manufacturing, healthcare product distribution, and research and development of new medical technologies. This diversified approach positions the company competitively in the healthcare industry, addressing both volume-driven consumables and technology-intensive equipment needs. Excelsior Medical Co., Ltd. continues to prioritize compliance with international quality standards and regulatory requirements in its manufacturing processes, facilitating its ongoing expansion into global healthcare markets and ensuring product reliability and safety. The company remains privately held with a focus on sustainable growth through innovation, strategic alliances, and enhanced customer service offerings. This description provides a comprehensive view of Excelsior Medical’s business activities, product offerings, recent strategic developments, and industry positioning.